CME Group Inc. (CME)
CME Group's Q1 Earnings and Revenues Miss Estimates, ADV Rises Y/Y
CME Group's Q1 EPS and revenues missed estimates, but heavier client activity lifted average daily volume 22% year over year.
CME Group Inc. (CME) Q1 2026 Earnings Call Transcript
CME Group Inc. (CME) Q1 2026 Earnings Call Transcript
CME (CME) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for CME (CME) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CME Group (CME) Q1 Earnings and Revenues Miss Estimates
CME Group (CME) came out with quarterly earnings of $3.36 per share, missing the Zacks Consensus Estimate of $3.37 per share. This compares to earnings of $2.8 per share a year ago.
CME Stock Under Pressure After Double Miss
CME Group Inc. (NASDAQ:CME) shares are trading lower Wednesday after the company reported worst-than-expected first-quarter earnings.
Can CME Group Retain Its Beat Streak This Earnings Season?
CME eyes first-quarter 2026 growth as volatility lifts volumes. Revenues are expected to be up 14% and EPS 17.9%.
Curious about CME (CME) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Evaluate the expected performance of CME (CME) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CME Group (CME) Earnings Expected to Grow: Should You Buy?
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
As Chicago Thaws In Spring, CME Group Remains A Hot Dividend Idea
CME Group gets a strong buy rating yet again, driven both by fundamental and technical factors, despite a neutral consensus. Company growth factors, macro-level tailwinds, strong margins, and low leverage combine to form a convincing mix. The dividend growth is proven over 10 years and many market cycles, while the payout ratio appears sustainable.
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
